SARS-CoV-2: the endocrinological protective clinical model derived from patients with prostate cancer
Ther Adv Endocrinol Metab
.
2020 Jul 11:11:2042018820942385.
doi: 10.1177/2042018820942385.
eCollection 2020.
Authors
Sandro La Vignera
1
,
Rossella Cannarella
2
,
Rosita A Condorelli
2
,
Francesco Torre
2
,
Antonio Aversa
3
,
Aldo E Calogero
2
Affiliations
1
Department of Clinical and Experimental Medicine, University of Catania, Via S. Sofia 78, Catania, 95123, Italy.
2
Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy.
3
Department of Experimental and Clinical Medicine, Magna Graecia University Catanzaro, Catanzaro, Italy.
PMID:
32699587
PMCID:
PMC7357014
DOI:
10.1177/2042018820942385
No abstract available
Keywords:
COVID-19; SARS-CoV2; androgen deprivation therapy; prostate cancer.